Global Topical Drug Delivery Market

Topical Drug Delivery Market Size, Share, Growth Analysis, By Product (Semi-Solid Formulations, Liquid Formulations), By Route of Administration (Dermal Drug Delivery, Ophthalmic Drug Delivery), By Facility of Use (Homecare Settings, Hospitals & Clinics), By Region - Industry Forecast 2025-2032

Report ID: SQMIG35D2106 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 64 | Figures: 75

Topical Drug Delivery Market News

  • In February 2022, Galderma and Taro Pharmaceutical Industries Ltd. announced a definitive agreement for Taro to acquire Alchemee, which is formerly The Proactiv Company, from Galderma. This agreement will add Proactiv to Taro's broad portfolio of prescription and over-the-counter dermatology products.
  • In February 2023, Coria Health announced the launch of its new topical drug delivery platform, Coria-TD. Coria-TD is a microneedle patch that can be used to deliver drugs to the skin in a targeted and controlled manner.
  • In March 2023, Akari Therapeutics plc announced the launch of its new topical drug delivery product, AkariQure. AkariQure is a gel that can be used to treat psoriasis and other skin conditions.
  • In April 2023, Innoplexus AG announced the launch of its new topical drug delivery platform, Innoplexus-TD. Innoplexus-TD is a nanoemulsion that can be used to deliver drugs to the skin in a targeted and controlled manner.
  • In May 2023, Transdermal Delivery Sciences Inc. announced the launch of its new topical drug delivery product, TD-04. TD-04 is a patch that can be used to deliver drugs to the skin in a targeted and controlled manner.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Topical Drug Delivery Market size was valued at USD 207.85 billion in 2022 and is poised to grow from USD 226.76 billion in 2023 to USD 455.17 billion by 2031, growing at a CAGR of 9.1% during the forecast period (2024-2031). 

The global topical drug delivery market is characterised by intense competition and a wide range of market players. This market segment encompasses the development and delivery of pharmaceutical products through topical routes, such as creams, gels, ointments, patches, and sprays, for local or systemic treatment of various diseases and conditions. 'Glenmark Pharmaceuticals Ltd. (India) ', 'Galderma (Switzerland) ', 'Johnson & Johnson Private Limited (US) ', 'GlaxoSmithKline Plc. (UK) ', 'Bausch Health Companies Inc. (Canada) ', 'Hisamitsu Pharmaceuticals Inc. (Japan) ', 'Cipla (India) ', 'Bayer AG (Germany) ', 'Viatris Inc. (Mylan N.V.) (US) ', '3M (US) ', 'Merck & Co., Inc. (Germany) ', 'Crescita Therapeutics Inc. (Canada) ', 'Novartis International AG (Switzerland) ', 'Boehringer Ingelheim International GmbH (Germany) ', 'Pfizer Inc. (US) ', 'Teva Pharmaceuticals Industries Ltd. (Israel) ', 'Bristol Myers Squibb (US) ', 'Lead Chemical Co., Ltd. (Japan) ', 'Purdue Pharma L.P. (US) ', 'Lavipharm (Greece) '

Topical drug delivery offers a convenient and non-invasive method of administering medications, eliminating the requirement for injections or oral medications. This feature is particularly advantageous for patients who may have a fear of needles or prefer a more comfortable and hassle-free approach. The use of topical formulations enhances treatment adherence and overall patient experience, making it a preferred option, especially for children and individuals with needle phobia.

The market is driven by the increasing prevalence of skin diseases, the rising ageing population, and the growing demand for non-invasive drug delivery methods. The development of new topical drug delivery technologies, such as microneedles and nanocarriers, is also expected to boost the market growth. However, the high cost of topical drug delivery products and the stringent regulatory requirements could restrain the market growth.

In the global topical drug delivery market share, the most dominant region is North America. North America has a well-established healthcare infrastructure, advanced research facilities, and a high prevalence of chronic diseases, driving the demand for topical drug delivery systems. The region is characterised by a strong presence of pharmaceutical companies and extensive R&D activities focused on innovative drug delivery technologies. Additionally, favourable government initiatives, robust reimbursement policies, and a high adoption rate of advanced healthcare technologies contribute to the dominance of North America in the global topical drug delivery market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Topical Drugs Market
Buy Now GET FREE SAMPLE
Drug Delivery Market
Buy Now GET FREE SAMPLE
Topical Pain Relief Market
Buy Now GET FREE SAMPLE
Controlled Release Drug Delivery Market
Buy Now GET FREE SAMPLE
Microneedle Drug Delivery Systems Market
Buy Now GET FREE SAMPLE
Connected Drug Delivery Devices Market
Buy Now GET FREE SAMPLE
Needle-free Drug Delivery Devices Market
Buy Now GET FREE SAMPLE
Moist Wound Dressings Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Topical Drug Delivery Market

Report ID: SQMIG35D2106

$5,300
BUY NOW GET FREE SAMPLE